PhaseBio Pharmaceuticals, Inc. (PHAS)
Interest Expense
$1.25M
TTM · Period ending: · USD
PHAS Interest Expense
Latest reported$1.25Mperiod ending
Latest reported$1.25Mperiod ending
PHAS Interest Expense ($0.00 → $1.25M)
Annual interest expense
High-resolution chart · PNG
PHAS interest expense history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Interest Expense (USD) |
|---|---|
| -947 | |
| 1,445,000 | |
| 1,076,000 | |
| 3,924,000 | |
| 2,723,000 | |
| 0 |